Mechanistic Considerations in 1,4-Dioxane Cancer Risk Assessment.

Area of Science:

• Toxicology
• Carcinogenesis
• Risk Assessment

Background:

• Risk assessment of carcinogens often requires extrapolating from high animal doses to low human exposures.
• 1,4-dioxane consistently causes liver cancer in rats and mice, necessitating a clear understanding of its mechanism for accurate risk assessment.
• Existing risk assessments for 1,4-dioxane have used varied extrapolation models (linear, non-linear, threshold) due to uncertainty in its cancer mechanism.

Purpose of the Study:

• To review potential modes of action for 1,4-dioxane-induced carcinogenesis.
• To identify data gaps in understanding 1,4-dioxane's carcinogenic mechanism.
• To evaluate the application of current knowledge to human risk assessment.

Main Methods:

• Literature review of 1,4-dioxane's toxicological and carcinogenic properties.
• Analysis of proposed mechanisms including cytotoxicity, metabolic saturation, oxidative stress, and genotoxicity.
• Evaluation of toxicokinetic data and induction of metabolic enzymes like CYP2E1.

Main Results:

• Cytotoxicity/hyperplasia and metabolic saturation hypotheses are insufficient to explain 1,4-dioxane's carcinogenicity.
• 1,4-dioxane induces its own metabolism, reducing the likelihood of saturation during chronic exposure.
• Evidence supports mechanisms involving oxidative stress and in vivo genotoxicity, distinct from in vitro findings.

Conclusions:

• The precise dose-response relationship for 1,4-dioxane's genotoxic and oxidative stress effects requires further investigation.
• 1,4-dioxane's effects may interact with existing human health factors contributing to liver cancer.
• A non-threshold linear approach is recommended for low-dose extrapolation of 1,4-dioxane's carcinogenic risk due to an undefined mode of action.